Happy Monday Zingernation! If you’ve been on social media at all over the weekend, chances are you’ve seen videos of people playing with their new Apple Vision Pro headsets. Or in some cases, getting pulled over while driving with one.

While the features are undoubtedly cool, like being able to watch a TikTok explaining the entire history of WWI and WWII in 60 seconds, some people are questioning the practicality of the device and whether technology is going too far. They also cost a pretty penny, with a starting price of $3,499. So, what do you think?

Before we dive in, check out the company that’s revolutionizing how we diagnose heart problems.

And, did someone forward you this email? Click here to subscribe to this Benzinga newsletter and more.

MARKET SNAPSHOT

Last Week: The market moved higher following strong earnings from $META and $AMZN. All major indices closed the week up more than 1% as the market flirted with new all-time highs.

On Our Radar: U.S. services PMI comes out at 9:45 am ET, and we will also continue the earnings train, with big companies like McDonald’s and Caterpillar set to report.

TOP STORY

Crypto Analyst Warns Of Bitcoin Downturn, Cites Tether Trends

Briefly: Well the journey to the moon may be slightly delayed for crypto. Cryptocurrency analyst Justin Bennett has warned about a possible downturn in Bitcoin's value.

Basically: Friday, in a post on X, formerly Twitter, Bennett suggested that Bitcoin may not have reached its market bottom yet. His prediction was based on the Tether dominance chart, which he believes is a crucial indicator for forecasting Bitcoin's trajectory.

Quoted: “The bottom is not in for BTC IMO (in my opinion). Maybe we see a mid $44,000 retest, but even markets like Tether dominance USDT.D are signaling another leg lower. This moves inversely to Bitcoin,” he said.

Check Out: The analyst’s full take on the crypto market here.

PRESENTED BY CARDIO DIAGNOSTICS

Cardio Diagnostics (NASDAQ: CDIO) Leverages AI To Combat The Leading Cause Of Death

Cardio Diagnostics (NASDAQ: CDIO) is at the forefront of a medical revolution, employing AI to combat the global crisis of cardiovascular disease — the single most common cause of death worldwide.

CDIO’s pioneering approach in Precision Cardiovascular Medicine utilizes AI-driven technology to enhance prevention and detection. It offers more effective, non-invasive alternatives to traditional heart disease testing, promising not only improved clinical outcomes, but also significant savings

FIVE ZINGERS

Job Well Done: Steve Jobs left Apple for more than 10 years in the ‘80s and ‘90s. Here’s how much you’d have if you invested when he returned.

Even The Home Supply: They say everything’s bigger in Texas… even the home supply. Here’s why Texas has the most homes available.

Here We Go Again: ‘Rich Dad Poor Dad’ author Robert Kiyosaki is calling for the stock and bond markets to crash… am I having deja vu?

Let’s Get To The Real News: Earnings schmearnings. The new Meta buzz is about Zuck’s hair and whether the billionaire is growing a mohawk.

Watch Out Elon: According to a recent Consumer Reports study, Tesla slipped to fifth place in a customer satisfaction poll, behind BMW, Rivian and more.

ONE FOR THE ROAD

Cathie Says Keep Calm And BTFD

Briefly: A lot of investors are starting to get more bearish on Tesla following the company’s underwhelming earnings report. But Cathie Wood keeps buying relentlessly.

So Basically: Cathie Wood, through her $ARKK and $ARKW funds, bought more than $1 million shares of Tesla each day last week.

Super Bull: Wood was undeterred by Tesla’s weaker numbers last quarter, and maintains a $2,000 price target on the stock. If it does end up hitting that price target, Wood is set to make more than 1,000% on the investment. =

What Next: Read more here.

A MESSAGE FROM CARDIO DIAGNOSTICS

Cardio Diagnostics' (NASDAQ: CDIO) Global Expansion: Transforming Cardiovascular Healthcare

Cardio Diagnostics (NASDAQ: CDIO) partners with Aimil Ltd., a leader in India's instrumentation industry, to tackle India's alarming cardiovascular disease rates. Leveraging Cardio Diagnostics' PrecisionCHD clinical test, this collaboration offers a personalized approach to manage coronary heart disease, addressing a critical health challenge in India and globally.

In the U.S., Cardio Diagnostics is making waves, teaming up with Family Medicine Specialists and Vizient, Inc. to provide advanced cardiovascular disease detection technology. Their AI-driven tests, Epi+Gen CHD and PrecisionCHD, offer valuable insights, allowing clinicians to personalize patient care and prevent severe cardiac events.

Join Cardio Diagnostics in revolutionizing global cardiovascular healthcare. Be part of a healthier future.